Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men

New England Journal of Medicine - Tập 363 Số 27 - Trang 2587-2599 - 2010
Robert M. Grant1,2, Javier R. Lama3,4, Peter L. Anderson5, Vanessa McMahan1, Albert Liu6,2, Lorena Vargas4, Pedro Goicochea1, Martín Casapía7, Juan Guanira3, Maria Esther Ramirez-Cardich3, Orlando Montoya-Herrera8, Telmo Fernández8, Valdiléa G. Veloso9, Susan Buchbinder6,2, Suwat Chariyalertsak10, Mauro Schechter11, Linda‐Gail Bekker12, Kenneth H. Mayer13,14, Esper G. Kallás15, K. Rivet Amico16,17, Kathleen Mulligan2, Lane R. Bushman5, Robert Hance1, Carmela Ganoza3, Patricia Defechereux1, Brian S. Postle18, Furong Wang2, John J. McConnell1, Jiahua Zheng5, Jeanny Lee1, James F. Rooney19, Howard S. Jaffe19, Ana I. Martínez20, David Burns20, David V. Glidden2
1Gladstone Institute of Virology and Immunology
2University of California San Francisco
3Asociación Civil Impacta Salud y Educación, Lima
4Investigaciones Medicas en Salud, Lima
5University of Colorado, Denver
6HIV Research Section, San Francisco Department of Public Health
7Asociación Civil Selva Amazónica, Iquitos
8Fundación Ecuatoriana Equidad, Guayaquil, Ecuador
9Instituto de Pesquisa Clinica Evandro Chagas–Fundação Oswaldo Cruz
10Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand
11Projeto Praça Onze, Hospital Escola São Francisco de Assis, Universidade Federal do Rio de Janeiro
12Desmond Tutu HIV Centre and Department of Medicine, University of Cape Town, Cape Town, South Africa
13Brown University, Providence, RI
14Fenway Institute, Fenway Health, Boston
15Division of Clinical Immunology and Allergy, School of Medicine, University of São Paulo, and Instituto de Investigação em Imunologia — both in São Paulo
16Applied Health Research, Brighton, MI
17Center for Health, Intervention, and Prevention, University of Connecticut, Storrs
18DF/Net Research, Seattle
19Gilead Sciences, Foster City, CA
20Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1016/S0140-6736(10)60705-2

10.1056/NEJM199411033311801

Smith DK, 2005, MMWR Recomm Rep, 54, 1

10.1097/00126334-200404150-00010

10.1086/497268

10.1126/science.1116204

10.1371/journal.pmed.0050016

10.1126/science.270.5239.1197

10.1086/322781

10.1371/journal.pmed.0050028

10.1126/scitranslmed.3000391

10.1371/journal.pctr.0020027

10.1126/science.1193748

10.1097/COH.0b013e32832c3bb3

10.1093/epirev/mxq011

10.1097/QAI.0b013e31815e4041

10.1097/QAI.0b013e31818d5a27

Good participatory practice: guidelines for biomedical HIV prevention trials. Geneva: UNAIDS, 2007.

Liu A, Vittinghoff E, Gandhi M, et al. Validating measures of tenofovir drug exposure in a US pre-exposure prophylaxis trial. In: Program and abstracts of the 17th Conference on Retroviruses and Opportunistic Infections, San Francisco, February 27–March 2, 2010.

10.1097/QAI.0b013e318162afcb

Schacker TW, 1998, Ann Intern Med, 128, 613, 10.7326/0003-4819-128-8-199804150-00001

10.1097/00126334-200010010-00014

10.1097/QAD.0b013e3283112b8e

10.1186/1758-2652-13-13

10.1097/00002030-200403260-00010

10.1001/jama.300.5.520

10.1016/S0140-6736(04)16588-4

10.1371/journal.pmed.0020298

10.1016/S0140-6736(07)60312-2

10.1016/S0140-6736(07)60313-4

10.1097/QCO.0b013e328334e54d

10.1093/ije/dyq057